The first treatment that works right in your kidney to fight low-grade UTUC

JELMYTO is the first and only FDA-approved treatment for low-grade UTUC. It is a combination of chemotherapy (mitomycin) and an innovative gel technology that is a liquid when chilled and turns into a gel at body temperature. Your doctor can give you JELMYTO right in the area where your tumors are. This makes JELMYTO different from traditional chemotherapy, which goes everywhere in your body.

Results with JELMYTO

See how JELMYTO helped patients with low-grade UTUC.

See study resultsArrow (right) icon

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit http://www.fda.gov/medwatch or call 1-800-FDA-1088. You may also report side effects to UroGen Pharma at 1-855-987-6436.

Please click here for JELMYTO Full Prescribing Information, including the Patient Information, for additional information.

Please click here for Full Prescribing Information, Instructions for Pharmacy and Instructions for Administration.